Treatment of glucocorticoid-induced protein wasting

Phase 2

Recruiting

• Conditions: ong-term glucocorticoid users with polymyalgia rheumatica; Inflammatory arthritis; Long-term glucocorticoid users with polymyalgia rheumatica; Inflammatory and Immune System - Rheumatoid arthritis

• Registration Number: ACTRN12605000642684
• Lead Sponsor: St Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Receiving prednisone for > 6 months for polymyalgia rheumatica or inflammatory arthritis.

Exclusion Criteria

Diabetes mellitus, cancer, liver or kidney failure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified